(Q34512338)

2 August 2017

title

The effect of propranolol on CSF amine metabolites in psychiatric patients (English)

1 reference

2 August 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1983.TB01507.X

24 August 2023

author name string

D. J. King

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189502

24 August 2023

S. J. Cooper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189502

24 August 2023

J. Liddle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189502

24 August 2023

language of work or name

English

0 references

publication date

1 March 1983

1 reference

full work available at URL

2 August 2017

https://europepmc.org/articles/PMC1427775

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189502

https://europepmc.org/articles/PMC1427775?pdf=render

24 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189502

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1983.tb01507.x

24 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1983.TB01507.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1983.tb01507.x/fullpdf

24 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1983.TB01507.X

British Journal of Clinical Pharmacology

24 August 2023

published in

1 reference

2 August 2017

volume

15

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

331-337

1 reference

The effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Diagnostic Criteria for Use in Psychiatric Research

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Propranolol in the control of schizophrenic symptoms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Unwanted effects of propranolol.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Visual hallucinations and propranolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Effects of chronic (+/-)-propranolol on catecholamines and GABA in rat striatum [proceedings]

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

The significance of dopamine for the mode of action of neuroleptics and the pathogenesis of schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

A standardized psychiatric assessment scale for rating chronic psychotic patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Visual hallucinations and illusions with propranolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Schizophrenia-like psychosis following administration of propranol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Tyrosine hydroxylase activity in rat brain regions after chronic treatment with ±-propranolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Antagonism by propranolol of the ganglion stimulant action of 5-hydroxytryptamine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Propranolol as an adjunct to the treatment of schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Chronic high dose propranolol does not increase dopamine receptor number

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Central Nervous Actions of β-Adrenoreceptor Antagonists

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Does dopamine play a role in schizophrenia?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Blockade of 5-hydroxytryptamine receptors in the central nervous system by β-adrenoceptor antagonists

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

(−)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427775

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1983.TB01507.X

A simple and reliable subclassification of chronic schizophrenia

21 January 2018

1 reference

12 December 2020

The influence of 1-(o-allylphenoxy)-3-isopropylamino-2-propanol hydrochloride (alprenolol) on the central nervous system of the rat

1 reference

12 December 2020

Estimation of catecholamines in urine by high performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Safeguards in the treatment of schizophrenia with propranolol

1 reference

12 December 2020

Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients

1 reference

12 December 2020

Decrease in serum-prolactin after propranolol in schizophrenia

1 reference

12 December 2020

The effects of amitriptyline, mianserin, phenoxybenzamine and propranolol on the release of noradrenaline in the rat brain in vivo

1 reference

12 December 2020

Rapid liquid-chromatographic measurement of 3-methoxy-4-hydroxyphenylglycol and other monoamine metabolites in human cerebrospinal fluid

1 reference

12 December 2020

Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients

1 reference

12 December 2020

Some clinical and metabolic aspects of propranolol in chronic schizophrenia

1 reference

12 December 2020

The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection

1 reference

12 December 2020

Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics

1 reference

12 December 2020

Effects of metergoline on regional serotonin metabolism in the rat brain

1 reference

12 December 2020

Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo

1 reference

12 December 2020

Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine

1 reference

12 December 2020

A trial of propranolol in chronic schizophrenia

1 reference

12 December 2020

The effect of dl-, l- and d-Propranolol on central monoamine neurones I. Studies on dopamine mechanisms

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1983.TB01507.X

Neuroendocrine Tests during Treatment with Neuroleptic Drugs. I. Plasma Prolactin Response to Haloperidol Challenge

24 August 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1983.TB01507.X

24 August 2023

Identifiers

1 reference

2 August 2017

1 reference

2 August 2017

1 reference